Skip to main content
OpenTrials
Completed

NCT Number: NCT04640558

Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects

This study aimed to investigate the relationship between latent MTrPs and gluteus medius muscle strength in a group of healthy adults.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

Male

Study type

Observational

Primary location

Biruni University Faculty of Medicine

Istanbul, 34100, Turkey (Türkiye)

About this study

Latent myofascial trigger points (MTrPs) do not cause spontaneous pain; however, they may lead to a limited range of motion and muscle weakness. We hypothesized that latent MTrPs might decrease gluteus medius muscle strength in healthy individuals. Forty-eight healthy men will be included in the study. Trigger point examination for the gluteus medius will be performed bilaterally. Subjects with one or more trigger points on the dominant side and those without any trigger points will be assigned to two groups. Muscle strength for gluteus medius will be assessed with a manual muscle tester using the "break test" technique on both sides. The subjects and the examiners will be blinded. For statistical analysis, the independent sample t-test was used to compare the intergroup differences.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient age: 18-40 years.
  • Absence of musculoskeletal complaints related to the lumbar, sacroiliac, and hip area.
  • Absence of bilateral latent MTrP in the gluteus medius muscle.
  • Latent trigger point in the gluteus medius muscle on the dominant side with palpation.

Exclusion criteria

  • A history of medical treatment, physical therapy, injection therapy, or surgical treatment related to the lumbar, sacroiliac, and hip area.
  • History of trauma, or malignancy or being pregnant, or if the patient is in the lactation period.
  • Bilateral latent MTrP in the gluteus medius muscle.
  • Presence of latent MTrP on the non-dominant side.

Treatment and study plan

Muscle strength measurement

Device

The bilateral gluteus medius muscle strength of each participant will be measured by the assessor (MB) blinded to the participants using the Lafayette manual muscle tester. (Lafayette Instrument Company, Lafayette IN, USA). In the participant's side-lying position, the practitioner applied resistance from the upper ankle to the abduction movement with slight flexion of the upper hip. During the measurements, the participants were asked to perform the maximum isometric contraction for 3 seconds. Gluteus medius muscle strength measurements were repeated three times, one minute apart, on the right and left sides. The mean of the measurements was calculated and recorded

Primary outcomes

  1. Gluteus medius muscle strength

    Time frame: One month

    In the participant's side-lying position, the practitioner will be applied resistance from the upper ankle to the abduction movement with slight flexion of the upper hip. During the measurements, the participants will be asked to perform the maximum isometric contraction for 3 seconds. Gluteus medius muscle strength measurements will be repeated three times, one minute apart, on the right and left sides. The mean of the measurements will be calculated and recorded

Sponsors and collaborators

Lead sponsor

Kars State Hospital

Other

Registry information

Official study title

The Relationship Between Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Nov 23, 2020
Registry last updated
Jan 29, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.